HAND2 and neoplasm: This study identified bioinformatically and experimentally the tumor-suppressive role of lncRNA HAND2-AS1 in HGSC and demonstrated for the first time its increase in HGSC cells when treated with the chemotherapeutic HDAC inhibitor Panobinostat.